Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksZotefoams Plc Regulatory News (ZTF)

Share Price Information for Zotefoams Plc (ZTF)

Share Price is delayed by 15 minutes
Get Live Data
419.00    -3.00 (-0.71%)
Bid:
420.50
Ask:
422.00
Spread: 1.50 (0.357%)
Market Cap: £206.07m
ZTF Live PriceLast checked at - London Stock Exchange

Intraday Zotefoams Plc Share Chart

Trading Update

8 Jul 2013 07:00

RNS Number : 7580I
Zotefoams PLC
08 July 2013
 



8 July 2013

 

 

 

Zotefoams plc

("Zotefoams" or "the Company")

 

 

Trading Update

 

 

8 July 2013 - Zotefoams, which manufactures and sells high-performance foams, today announces its trading update for the first six months ended 30 June 2013.

 

Since our AGM and Interim Management Statement on 15 May 2013 the Company has experienced improved overall trading with a good level of sales in the final two months of the half year ended 30 June 2013. This has been driven in particular by growth in our High-Performance Polymers ("HPP") and MuCell Extrusion LLC ("MEL") businesses.

 

In the period to 30 June 2013 sales in our Azote® polyolefin business were below what was a very strong comparative period last year. Primarily this is due to customer destocking, most evident in Germany and Japan coincident with improvements in our order lead times, and a lower underlying level of sales in continental Europe.

 

The price of our main raw material, LDPE (low density polyethylene), eased in April and May so that the average Euro price for the period was similar to that in the first six months of 2012. Compared with the same period, currency rates for the US dollar and Euro have remained beneficial for our export-led business.

 

Overall sales growth in HPP and MEL has not fully offset the lower level of sales in our Azote® polyolefin foams business, particularly in the earlier part of the period and in continental Europe. This will result in a profit for the first half of 2013 below that of a strong first half in 2012.

 

We continue to invest to support future growth across the portfolio of our activities and, while being mindful of near-term economic conditions, the Board remains confident about the long-term prospects for our business.

 

The Company expects to announce its interim results for the six months ended 30 June 2013 and provide an update on current trading on Tuesday, 6 August 2013.

 

 

Enquiries:

Zotefoams plc

0208-664-1600

David Stirling, Managing Director

Clifford Hurst, Finance Director

FTI Consulting

0207-831-3113

John Dineen, Victoria Foster Mitchell

 

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular material technology. Using a unique manufacturing process with environmentally friendly nitrogen expansion, Zotefoams produces lightweight foams in Croydon, UK and Kentucky, USA for diverse markets worldwide through its global sales force. Zotefoams also owns and licenses patented MuCell® microcellular foam technology from a base in Massachusetts, USA to customers worldwide and sells T-Tubes® advanced insulation systems made from its patented ZOTEK® fluoropolymer foams.

 

www.zotefoams.com

 

 

Cautionary statement regarding forward-looking statements

This document may contain forward-looking statements which are made in good faith and are based on current expectations or beliefs, as well as assumptions about future events. You can sometimes, but not always, identify these statements by the use of a date in the future or such words as "will", "anticipate", "estimate", "expect", "project", "intend", "plan", "should", "may", "assume" and other similar words. By their nature, forward-looking statements are inherently predictive and speculative and involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future. You should not place undue reliance on these forward-looking statements, which are not a guarantee of future performance and are subject to factors that could cause our actual results to differ materially from those expressed or implied by these statements. The Company undertakes no obligation to update any forward-looking statements contained in this document, whether as a result of new information, future events or otherwise.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTMMGGNNKGGFZM
Date   Source Headline
12th Apr 20244:34 pmRNSNotification Of Transactions Of Directors/PDMRs
28th Mar 20247:00 amRNSDirector/PDMR Shareholding
26th Mar 20248:36 amRNSReplacement Notice Transactions Of Directors/PDMRs
26th Mar 20247:00 amRNSGroup CEO succession
25th Mar 20245:58 pmRNSNotification Of Transactions Of Directors/PDMRs
22nd Mar 20245:31 pmRNSHolding(s) in Company
19th Mar 20247:00 amRNSPreliminary Results
12th Mar 20241:41 pmRNSNotification Of Transactions Of Directors/PDMRs
14th Feb 20247:00 amRNSZotefoams joins independent authority, RECOUP
13th Feb 202412:31 pmRNSNotification Of Transactions Of Directors/PDMRs
7th Feb 20247:00 amRNSNotice of results and investor presentation
5th Feb 20241:20 pmRNSHolding(s) in Company
22nd Jan 20241:58 pmRNSHolding(s) in Company
18th Jan 20247:00 amRNSFull Year Trading Update
12th Jan 20245:13 pmRNSDirector/PDMR Shareholding
12th Jan 202412:28 pmRNSNotification Of Transactions Of Directors/PDMRs
5th Jan 202412:47 pmRNSReplacement Holding(s) in Company
4th Jan 20243:24 pmRNSHolding(s) in Company
4th Jan 20241:17 pmRNSHolding(s) in Company
13th Dec 20234:49 pmRNSHolding(s) in Company
13th Dec 20234:31 pmRNSReplacement Notice Transactions Of Directors/PDMRs
13th Dec 20231:54 pmRNSHolding(s) in Company
12th Dec 20233:46 pmRNSNotification Of Transactions Of Directors/PDMRs
12th Dec 202312:45 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Dec 20231:53 pmRNSNotification Of Transactions Of Directors/PDMRs
27th Nov 20237:00 amRNSTop industry award for ReZorce® beverage cartons
14th Nov 202311:56 amRNSNotification Of Transactions Of Directors/PDMRs
8th Nov 20235:38 pmRNSHolding(s) in Company
7th Nov 20237:01 amRNSGroup CEO succession
7th Nov 20237:00 amRNSTrading Update
31st Oct 20237:00 amRNSZotefoams programme extension at Nike
12th Oct 202312:09 pmRNSNotification Of Transactions Of Directors/PDMRs
11th Oct 20239:47 amRNSNotification Of Transactions Of Directors/PDMRs
29th Sep 20237:00 amRNSBoard Changes
18th Sep 20234:45 pmRNSHolding(s) in Company
12th Sep 202310:57 amRNSNotification Of Transactions Of Directors/PDMRs
5th Sep 20234:07 pmRNSHolding(s) in Company
31st Aug 20233:14 pmRNSHolding(s) in Company
29th Aug 20237:00 amRNSInvestor presentation on Investor Meet Company
25th Aug 20237:00 amRNSIssue of Equity
14th Aug 20231:51 pmRNSNotification of Transactions of Directors/PDMRs
9th Aug 20233:29 pmRNSHolding(s) in Company
8th Aug 20237:00 amRNSInterim Results
19th Jul 20231:29 pmRNSHolding(s) in Company
18th Jul 20237:00 amRNSJoint development agreement for ReZorce®
12th Jul 202311:01 amRNSNotification Of Transactions Of Directors/PDMRs
10th Jul 20237:00 amRNSNotice of results and investor presentation
22nd Jun 20232:20 pmRNSHolding(s) in Company
20th Jun 202310:16 amRNSNotification Of Transactions Of Directors/PDMRs
14th Jun 20237:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.